Point72 (DIFC)’s Gossamer Bio GOSS Stock Holding History

Point72 (DIFC)’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,700	Closed	-$14K	–	1773
2025 Q1	$14K	Buy	+12,700	New	+$14.7K	﹤0.01%	1409

Other funds holding GOSS

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Point72 (DIFC)'s GOSS Position: Q2 2025 in Review

Point72 (DIFC) sold out of Gossamer Bio (GOSS) in Q2 2025, closing a stake of 12,700 shares — an estimated $14K sold.

Point72 (DIFC) first reported a position in GOSS in Q1 2025 and held it in 1 quarter. The position peaked at $14K in Q1 2025. 123 funds tracked by Wall St. Rank hold GOSS as of Q2 2025.

Point72 (DIFC) reported no remaining Gossamer Bio position as of Q2 2025 after selling out during the quarter.
Point72 (DIFC) sold 12,700 Gossamer Bio shares in Q2 2025, an estimated $14K.
Point72 (DIFC) first reported a position in Gossamer Bio in Q1 2025 and held it in 1 quarter.
Point72 (DIFC)'s Gossamer Bio position peaked at $14K in Q1 2025.
123 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.